UNITED THERAPEUTICS CORP (UTHR) Institutional Ownership Changes & 13F Activity

UNITED THERAPEUTICS CORP (UTHR) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Sequoia Financial Advisors, Mairs & Power Growth Fund, Hancock Classic Value, and First Eagle U.S. Value.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2016Renaissance Technologies LLCSell-70,278404,300$42,823
Q1 2016Renaissance Technologies LLCSell-77,500474,578$52,882
Q4 2015Renaissance Technologies LLCSell-314,700552,078$86,461
Q3 2015First Eagle U.S. ValueBuy121,927548,807$72,025
Q3 2015Renaissance Technologies LLCBuy55,200866,778$113,756
Q2 2015Renaissance Technologies LLCBuy365,078811,578$141,174
Q2 2015First Eagle U.S. ValueBuy54,300426,880$74,256
Q1 2015Renaissance Technologies LLCBuy261,262446,500$76,992
Q1 2015First Eagle U.S. ValueBuy12,400372,580$64,246
Q4 2014Renaissance Technologies LLCBuy182,860185,238$23,986
Q4 2014First Eagle U.S. ValueBuy98,100360,180$46,640
Q3 2014First Eagle U.S. ValueBuy262,080262,080$33,717
Q3 2014Renaissance Technologies LLCSell-250,1002,378$306
Q2 2014Renaissance Technologies LLCSell-35,462252,478$22,342
Q1 2014Renaissance Technologies LLCBuy63,662287,940$27,075
Q4 2013Renaissance Technologies LLCSell-216,500224,278$25,361
Q3 2013Renaissance Technologies LLCSell-149,600440,778$34,755
Q2 2013Renaissance Technologies LLCBuy590,378590,378$38,859

Frequently asked questions about UTHR activity

  • Which institutional owners are buying UTHR?

    Institutional owners buying UTHR include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in UTHR activity?

    "Buy" means an investor increased their reported position in UTHR compared to the prior reporting period. This reflects growing exposure to UNITED THERAPEUTICS CORP (UTHR) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in UTHR increasing?

    Institutional interest in UTHR can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related UTHR insights